‘Grief Never Goes Away’: Community Rallies at Dunn With Cancer Run, Raises $1.6 Million for Brain Cancer Research iPAX‑2 Trial of TLX101 TX in First‑Line Glioblastoma Finishes Enrollment and Locks In Dosing Schedule A Glimmer of Hope: UNC Researchers Uncover Potent Combination Therapy for Aggressive Brain Cancer A Game-Changer in the Fight Against Glioblastoma: Kingston's Ingenious 3D-Printed Biopsy Tool